APA (7th ed.) Citation

Wang, H., Tian, Q., Zhang, R., Du, Q., Hu, J., Gao, T., . . . Dong, H. (2024). Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway. Lipids in Health & Disease, 23(1), 1. https://doi.org/10.1186/s12944-024-02049-5

Chicago Style (17th ed.) Citation

Wang, Heng, et al. "Nobiletin Alleviates Atherosclerosis by Inhibiting Lipid Uptake via the PPARG/CD36 Pathway." Lipids in Health & Disease 23, no. 1 (2024): 1. https://doi.org/10.1186/s12944-024-02049-5.

MLA (9th ed.) Citation

Wang, Heng, et al. "Nobiletin Alleviates Atherosclerosis by Inhibiting Lipid Uptake via the PPARG/CD36 Pathway." Lipids in Health & Disease, vol. 23, no. 1, 2024, p. 1, https://doi.org/10.1186/s12944-024-02049-5.